ANTIPODAL ALPHA-N-(METHYL THROUGH DECYL)-N-NORMETAZOCINES (5,9-ALPHA-DIMETHYL-2'-HYDROXY-6,7-BENZOMORPHANS) - IN-VITRO AND IN-VIVO PROPERTIES
ANTIPODAL ALPHA-N-(METHYL THROUGH DECYL)-N-NORMETAZOCINES (5,9-ALPHA-DIMETHYL-2'-HYDROXY-6,7-BENZOMORPHANS) - IN-VITRO AND IN-VIVO PROPERTIES
复制标题
DOI:
10.1021/jm00046a026
复制
发表时间:
1994-09-30
影响因子:
7.3
通讯作者:
JACOBSON, AE
中科院分区:
文献类型:
--
作者:
MAY, EL;ACETO, MD;JACOBSON, AE
The enantiomeric (-)- and (+)-N-(methyl through decyl) normetazocines (5,9 alpha-dimethyl-2'hydroxy-6,7-benzomorphans) were synthesized and their in vitro and in vivo activities determined. Increasingly bulky enantiomeric N-alkyl homologs were prepared until their interaction with the or receptor decreased and their insolubility became a hindrance to their evaluation in vivo and/or in vitro. The(-)-methyl, -pentyl, -hexyl, and -heptyl homologs were essentially as potent as, or more potent than, morphine in the tail-flick, phenylquinone, and hot-plate assays for antinociceptive activity; the (-)-propyl homolog had narcotic antagonist activity between that of nalorphine and naloxone in the tail-flick vs morphine assay, and it also displayed antagonist properties in the single-dose suppression assay in the rhesus monkey. The antinociceptively potent (-)-heptyl homolog did not substitute for morphine in monkeys but did show morphine-like properties in a primary physical-dependence study in continuously infused rats. All five potent compounds showed high affinity for the mu opioid receptor from both rat and monkey preparations and the kappa opioid receptor (